FRIDAY, June 24, 2022 — For patients with AIDS-related lymphoma (ARL), hypoalbuminemia predicts inferior outcome, according to a study published online June 18 in Infectious Agents and Cancer.
Jinxin Zhang, from Nanfang Hospital in Guangzhou, China, and colleagues retrospectively analyzed de novo ARL patients from 2013 to 2019 to examine factors correlating with progression-free survival (PFS) and overall survival (OS). Eighty-six ARL patients were enrolled and followed for a median of 34 months.
The researchers found that the OS and two-year PFS rates were 37.5 and 35.4 percent, respectively, in the cohort. Inferior survival was predicted by older age and hypoalbuminemia in multivariate models. Worse OS and two-year PFS were seen for ARL patients with hypoalbuminemia, which was associated with poor Eastern Cooperative Oncology Group performance status and a higher International Prognosis Index score.
“We showed that hypoalbuminemia is a simple and effective prognostic factor in AIDS-related lymphoma patients,” the authors write. “For ARL patients with hypoalbuminemia, closer follow-up and timely intervention are necessary.”
© 2022 HealthDay. All rights reserved.
Posted June 2022
More news resources
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.